50 related articles for article (PubMed ID: 25331234)
1. Ursodeoxycholic acid decreases bilirubin-induced osteoblast apoptosis.
Ruiz-Gaspà S; Dubreuil M; Guañabens N; Combalia A; Peris P; Monegal A; Parés A
Eur J Clin Invest; 2014 Dec; 44(12):1206-14. PubMed ID: 25331234
[TBL] [Abstract][Full Text] [Related]
2. Bilirubin increases viability and decreases osteoclast apoptosis contributing to osteoporosis in advanced liver diseases.
Jurado S; Parés A; Peris P; Combalia A; Monegal A; Guañabens N
Bone; 2022 Sep; 162():116483. PubMed ID: 35787483
[TBL] [Abstract][Full Text] [Related]
3. Oral Ursodeoxycholic Acid Crosses the Blood Retinal Barrier in Patients with Retinal Detachment and Protects Against Retinal Degeneration in an Ex Vivo Model.
Daruich A; Jaworski T; Henry H; Zola M; Youale J; Parenti L; Naud MC; Delaunay K; Bertrand M; Berdugo M; Kowalczuk L; Boatright J; Picard E; Behar-Cohen F
Neurotherapeutics; 2021 Apr; 18(2):1325-1338. PubMed ID: 33537951
[TBL] [Abstract][Full Text] [Related]
4. Ursodeoxycholic acid loaded dual-modified graphene oxide nanocomposite alleviates cholestatic liver injury through inhibiting hepatocyte apoptosis.
Zhou W; Yang X; Yin Y; Chen S; Yang L; Li T; Liu J; Lu B; Yang Z; Li R; Zhang M
Colloids Surf B Biointerfaces; 2024 Jun; 238():113904. PubMed ID: 38603845
[TBL] [Abstract][Full Text] [Related]
5. Ursodeoxycholic Acid (UDCA) Reduces Hepatocyte Apoptosis by Inhibiting Farnesoid X Receptor (FXR) in Hemorrhagic Shock (HS).
Wang L; Rui X; He HW; Zhou X; Long Y
Curr Mol Med; 2023; 23(6):550-558. PubMed ID: 35619282
[TBL] [Abstract][Full Text] [Related]
6. The biocompatibility and the metabolic impact of thermoresponsive, bile acid-based nanogels on auditory and macrophage cell lines.
Kovacevic B; Raj Wagle S; Mihaela Ionescu C; Foster T; Đanić M; Mikov M; Mooranian A; Al-Salami H
Eur J Pharm Biopharm; 2023 Sep; 190():248-257. PubMed ID: 37562725
[TBL] [Abstract][Full Text] [Related]
7. Effect of Enterococcus faecalis OG1RF on human calvarial osteoblast apoptosis.
Li Y; Sun S; Wen C; Zhong J; Jiang Q
BMC Oral Health; 2022 Jul; 22(1):279. PubMed ID: 35804353
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid as a potential alternative therapeutic approach for neurodegenerative disorders: Effects on cell apoptosis, oxidative stress and inflammation in the brain.
Huang F
Brain Behav Immun Health; 2021 Dec; 18():100348. PubMed ID: 34632427
[TBL] [Abstract][Full Text] [Related]
9. A novel heteroleptic Cu(II)-phenanthroline-UDCA complex as lipoxygenase inhibitor and ER-stress inducer in cancer cell lines.
Masuri S; Moráň L; Vesselá T; Cadoni E; Cabiddu MG; Pečinka L; Gabrielová V; Meloni F; Havel J; Vaňhara P; Pivetta T
J Inorg Biochem; 2023 Sep; 246():112301. PubMed ID: 37392615
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid production by Gibberella zeae mutants.
Kollerov V; Donova M
AMB Express; 2022 Aug; 12(1):105. PubMed ID: 35939125
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid exerts farnesoid X receptor-antagonistic effects on bile acid and lipid metabolism in morbid obesity.
Mueller M; Thorell A; Claudel T; Jha P; Koefeler H; Lackner C; Hoesel B; Fauler G; Stojakovic T; Einarsson C; Marschall HU; Trauner M
J Hepatol; 2015 Jun; 62(6):1398-404. PubMed ID: 25617503
[TBL] [Abstract][Full Text] [Related]
12. Bile acids and bilirubin effects on osteoblastic gene profile. Implications in the pathogenesis of osteoporosis in liver diseases.
Ruiz-Gaspà S; Guañabens N; Jurado S; Dubreuil M; Combalia A; Peris P; Monegal A; Parés A
Gene; 2020 Jan; 725():144167. PubMed ID: 31639434
[TBL] [Abstract][Full Text] [Related]
13. A Rare Case of Primary Sjogren's Syndrome Coexisting With Gilbert Syndrome.
Zhang L; Liu Z; Xue L
Cureus; 2023 Sep; 15(9):e45521. PubMed ID: 37868557
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for fractures following liver transplantation: a population-based cohort study.
Chang JW; Yang HH; Lin NC; Kuo FC; Lin TC; Tsai HL
Ann Med; 2023 Dec; 55(1):2230871. PubMed ID: 37455447
[TBL] [Abstract][Full Text] [Related]
15. Association between osteoporosis and hepatitis B cirrhosis: a case-control study.
Zhang Y; Gao X; Liu T; Gao P; Li H; Liu N; Gao L; Wan G; Zhang Y; Duan X
Afr Health Sci; 2020 Dec; 20(4):1610-1616. PubMed ID: 34394221
[TBL] [Abstract][Full Text] [Related]
16. An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia.
Yang YJ; Kim DJ
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33807573
[TBL] [Abstract][Full Text] [Related]
17. Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart.
Hanafi NI; Mohamed AS; Sheikh Abdul Kadir SH; Othman MHD
Biomolecules; 2018 Nov; 8(4):. PubMed ID: 30486474
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective Effect of ω-3 Polyunsaturated Fatty Acids on Bilirubin Encephalopathy In Vitro and In Vivo.
Hao W; Song J; Li G
Med Sci Monit; 2018 Apr; 24():2631-2638. PubMed ID: 29704452
[TBL] [Abstract][Full Text] [Related]
19. Children and adolescents with cystic fibrosis display moderate bone microarchitecture abnormalities: data from high-resolution peripheral quantitative computed tomography.
Braun C; Bacchetta J; Braillon P; Chapurlat R; Drai J; Reix P
Osteoporos Int; 2017 Nov; 28(11):3179-3188. PubMed ID: 28795206
[TBL] [Abstract][Full Text] [Related]
20. Low bone mineral density and the severity of cholestasis in biliary atresia.
Homchan K; Chaiwatanarat T; Udomsinprasert W; Chongsrisawat V; Poovorawan Y; Honsawek S
World J Hepatol; 2017 Jun; 9(16):746-751. PubMed ID: 28652893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
